Symbols / EHC Stock $100.92 -1.04% Encompass Health Corporation

Healthcare • Medical Care Facilities • United States • NYQ
EHC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Mark J. Tarr
Exch · Country NYQ · United States
Market Cap 10.03B
Enterprise Value 13.51B
Income 565.70M
Sales 5.94B
FCF (ttm) 296.79M
Book/sh 24.38
Cash/sh 0.73
Employees 24,611
Insider 10d
IPO Sep 24, 1986
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 12.97%
P/E 18.18
Forward P/E 15.57
PEG 0.41
P/S 1.69
P/B 4.14
P/C
EV/EBITDA 9.78
EV/Sales 2.28
Quick Ratio 0.83
Current Ratio 1.08
Debt/Eq 82.85
LT Debt/Eq
EPS (ttm) 5.55
EPS next Y 6.48
EPS Growth 21.20%
Revenue Growth 9.90%
EPS Gr Q/Q 20.80%
Rev Gr Q/Q
Earnings (next) 2026-04-30
Earnings (prior) 2026-02-05
ROA 9.66%
ROE 24.82%
ROIC
Gross Margin 43.21%
Oper. Margin 18.35%
Profit Margin 9.54%
Shs Outstand 99.42M
Shs Float 98.16M
Insider Own 1.05%
Instit Own 101.33%
Short Float 3.46%
Short Ratio 3.16
Short Interest 3.05M
52W High 127.99
vs 52W High -21.15%
52W Low 92.77
vs 52W Low 8.79%
Beta 0.60
Impl. Vol. 53.52%
Rel Volume 0.44
Avg Volume 1.13M
Volume 489.96K
Target (mean) $142.73
Tgt Median $140.00
Tgt Low $130.00
Tgt High $160.00
# Analysts 11
Recom Strong_buy
Prev Close $101.98
Price $100.92
Change -1.04%
About

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$100.92
Low
$130.00
High
$160.00
Mean
$142.73

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-06 main Barclays Overweight → Overweight $153
2025-10-30 main Barclays Overweight → Overweight $150
2025-10-02 main UBS Buy → Buy $150
2025-09-16 main Keybanc Overweight → Overweight $140
2025-09-10 main B of A Securities Buy → Buy $160
2025-08-14 main Truist Securities Buy → Buy $140
2025-08-06 main UBS Buy → Buy $140
2025-06-05 reit Stephens & Co. Overweight → Overweight $135
2025-05-27 main Keybanc Overweight → Overweight $135
2025-04-28 main UBS Buy → Buy $130
2025-04-28 main RBC Capital Outperform → Outperform $125
2025-04-28 reit Truist Securities Buy → Buy $135
2025-04-25 main Keybanc Overweight → Overweight $122
2025-04-25 main Barclays Overweight → Overweight $129
2025-02-11 reit RBC Capital Outperform → Outperform $110
2025-02-10 main Keybanc Overweight → Overweight $120
2025-02-07 main Barclays Overweight → Overweight $118
2024-10-30 main RBC Capital Outperform → Outperform $110
2024-10-30 reit Truist Securities Buy → Buy $116
2024-10-29 main Barclays Overweight → Overweight $116
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-16 REIDY CHRISTOPHER R Director 353 $0.00 $35,564
2026-04-16 CHRISTIE EDWARD M III Director 270 $0.00 $27,710
2026-04-15 WILLIAMS TERRANCE Director 27 $0.00 $0
2026-04-15 O'CONNOR KEVIN J Director 17 $0.00 $0
2026-04-15 HAYES CAIN A. Director 1 $0.00 $0
2026-04-15 CARMICHAEL GREGORY D Director 27 $0.00 $0
2026-04-15 SCHLICHTING NANCY M Director 39 $0.00 $0
2026-04-15 KATZ LESLYE G Director 85 $0.00 $0
2026-04-15 HERMAN JOAN E Director 85 $0.00 $0
2026-03-09 FAY EDMUND M Officer and Treasurer 3,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
5,935.20
+10.46%
5,373.20
+11.91%
4,801.20
+10.41%
4,348.60
Operating Revenue
5,935.20
+10.46%
5,373.20
+11.91%
4,801.20
+10.41%
4,348.60
Cost Of Revenue
254.40
-91.90%
3,140.00
+11.41%
2,818.40
+8.59%
2,595.40
Reconciled Cost Of Revenue
254.40
-91.90%
3,140.00
+11.41%
2,818.40
+8.59%
2,595.40
Gross Profit
5,680.80
+154.38%
2,233.20
+12.63%
1,982.80
+13.10%
1,753.20
Operating Expense
4,627.70
+238.11%
1,368.70
+9.41%
1,251.00
+11.40%
1,123.00
Selling General And Administration
3,411.10
+1179.96%
266.50
+3.29%
258.00
+23.44%
209.00
General And Administrative Expense
3,411.10
+1179.96%
266.50
+3.29%
258.00
+23.44%
209.00
Salaries And Wages
3,115.90
2,600.10
+8.64%
2,393.30
Other Gand A
236.20
+12.91%
209.20
+3.72%
201.70
+30.72%
154.30
Other Operating Expenses
888.70
+10.73%
802.60
+11.61%
719.10
+7.26%
670.40
Total Expenses
4,882.10
+8.28%
4,508.70
+10.80%
4,069.40
+9.44%
3,718.40
Operating Income
1,053.10
+21.82%
864.50
+18.13%
731.80
+16.12%
630.20
EBITDA
1,404.10
+18.33%
1,186.60
+15.81%
1,024.60
+17.76%
870.10
Normalized EBITDA
1,404.10
+18.27%
1,187.20
+15.87%
1,024.60
+17.57%
871.50
Reconciled Depreciation
327.90
+9.45%
299.60
+9.38%
273.90
+12.44%
243.60
EBIT
1,076.20
+21.33%
887.00
+18.16%
750.70
+19.82%
626.50
Total Unusual Items
0.00
+100.00%
-0.60
0.00
+100.00%
-1.40
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-0.60
0.00
+100.00%
-1.40
Special Income Charges
0.00
+100.00%
-0.60
0.00
+100.00%
-1.40
Other Special Charges
0.60
1.40
Net Income
566.20
+24.25%
455.70
+29.46%
352.00
+29.89%
271.00
Pretax Income
953.00
+27.13%
749.60
+23.45%
607.20
+34.69%
450.80
Net Non Operating Interest Income Expense
-123.20
+10.33%
-137.40
+4.25%
-143.50
+18.33%
-175.70
Interest Expense Non Operating
123.20
-10.33%
137.40
-4.25%
143.50
-18.33%
175.70
Net Interest Income
-123.20
+10.33%
-137.40
+4.25%
-143.50
+18.33%
-175.70
Interest Expense
123.20
-10.33%
137.40
-4.25%
143.50
-18.33%
175.70
Other Income Expense
23.10
+2.67%
22.50
+19.05%
18.90
+610.81%
-3.70
Other Non Operating Income Expenses
18.80
-6.47%
20.10
+28.03%
15.70
+401.92%
-5.20
Tax Provision
192.90
+28.43%
150.20
+13.62%
132.20
+32.07%
100.10
Tax Rate For Calcs
0.00
+1.00%
0.00
-8.26%
0.00
-1.80%
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-0.12
0.00
+100.00%
-0.31
Net Income Including Noncontrolling Interests
759.10
+27.24%
596.60
+28.86%
463.00
+26.54%
365.90
Net Income From Continuing Operation Net Minority Interest
567.20
+23.71%
458.50
+25.96%
364.00
+42.30%
255.80
Net Income From Continuing And Discontinued Operation
566.20
+24.25%
455.70
+29.46%
352.00
+29.89%
271.00
Net Income Continuous Operations
760.10
+26.81%
599.40
+26.19%
475.00
+35.44%
350.70
Net Income Discontinuous Operations
-1.00
+64.29%
-2.80
+76.67%
-12.00
-178.95%
15.20
Minority Interests
-192.90
-36.91%
-140.90
-26.94%
-111.00
-16.97%
-94.90
Normalized Income
567.20
+23.58%
458.98
+26.09%
364.00
+41.70%
256.89
Net Income Common Stockholders
564.70
+24.69%
452.90
+29.55%
349.60
+29.58%
269.80
Otherunder Preferred Stock Dividend
1.50
-46.43%
2.80
+16.67%
2.40
+100.00%
1.20
Diluted EPS
5.54
+24.22%
4.46
+28.53%
3.47
+28.52%
2.70
Basic EPS
5.62
+24.06%
4.53
+29.06%
3.51
+29.04%
2.72
Basic Average Shares
100.50
+0.60%
99.90
+0.40%
99.50
+0.30%
99.20
Diluted Average Shares
102.20
+0.00%
102.20
+0.89%
101.30
+0.90%
100.40
Diluted NI Availto Com Stockholders
566.20
+24.25%
455.70
+29.46%
352.00
+29.89%
271.00
Average Dilution Earnings
1.50
-46.43%
2.80
+16.67%
2.40
+100.00%
1.20
Depreciation Amortization Depletion Income Statement
327.90
+9.45%
299.60
+9.38%
273.90
+12.44%
243.60
Depreciation And Amortization In Income Statement
327.90
+9.45%
299.60
+9.38%
273.90
+12.44%
243.60
Earnings From Equity Interest
4.30
+43.33%
3.00
-6.25%
3.20
+10.34%
2.90
Rent And Landing Fees
59.00
+2.97%
57.30
+1.78%
56.30
+2.93%
54.70
Rent Expense Supplemental
59.00
+2.97%
57.30
+1.78%
56.30
+2.93%
54.70
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
7,089.70
+8.49%
6,534.70
+7.08%
6,102.40
+8.27%
5,636.50
Current Assets
905.90
+2.14%
886.90
+5.36%
841.80
+17.37%
717.20
Cash Cash Equivalents And Short Term Investments
72.20
-15.46%
85.40
+23.59%
69.10
+216.97%
21.80
Cash And Cash Equivalents
72.20
-15.46%
85.40
+23.59%
69.10
+216.97%
21.80
Cash Financial
72.20
-15.46%
85.40
+23.59%
69.10
+216.97%
21.80
Receivables
619.20
+3.41%
598.80
-2.09%
611.60
+13.93%
536.80
Accounts Receivable
619.20
+3.41%
598.80
-2.09%
611.60
+13.93%
536.80
Prepaid Assets
53.90
+27.42%
42.30
+22.61%
34.50
-1.15%
34.90
Restricted Cash
30.70
-18.57%
37.70
+7.41%
35.10
+11.08%
31.60
Assets Held For Sale Current
0.00
Other Current Assets
129.90
+5.87%
122.70
+34.10%
91.50
-0.65%
92.10
Total Non Current Assets
6,183.80
+9.47%
5,648.80
+7.38%
5,260.60
+6.94%
4,919.30
Net PPE
4,314.20
+12.15%
3,846.80
+9.61%
3,509.50
+11.35%
3,151.70
Gross PPE
6,687.00
+12.22%
5,958.70
+10.72%
5,381.70
+11.86%
4,811.10
Accumulated Depreciation
-2,372.80
-12.35%
-2,111.90
-12.80%
-1,872.20
-12.82%
-1,659.40
Properties
0.00
0.00
0.00
0.00
Land And Improvements
339.70
+12.26%
302.60
+2.93%
294.00
+2.76%
286.10
Buildings And Improvements
4,325.70
+12.09%
3,859.30
+13.42%
3,402.80
+12.68%
3,019.80
Machinery Furniture Equipment
903.10
+10.89%
814.40
+11.78%
728.60
+11.80%
651.70
Construction In Progress
517.60
+27.52%
405.90
-5.82%
431.00
+19.89%
359.50
Other Properties
212.60
+4.37%
203.70
-2.30%
208.50
-1.88%
212.50
Leases
388.30
+4.16%
372.80
+17.68%
316.80
+12.54%
281.50
Goodwill And Other Intangible Assets
1,625.90
+2.72%
1,582.80
+1.49%
1,559.50
+0.91%
1,545.50
Goodwill
1,317.60
+2.62%
1,284.00
+0.21%
1,281.30
+1.43%
1,263.20
Other Intangible Assets
308.30
+3.18%
298.80
+7.40%
278.20
-1.45%
282.30
Other Non Current Assets
243.70
+11.18%
219.20
+14.41%
191.60
-13.73%
222.10
Total Liabilities Net Minority Interest
3,813.90
+3.48%
3,685.50
-3.15%
3,805.20
+0.81%
3,774.60
Current Liabilities
836.40
-0.55%
841.00
+28.12%
656.40
+13.98%
575.90
Payables And Accrued Expenses
476.70
+10.78%
430.30
+2.43%
420.10
+22.12%
344.00
Payables
233.00
+15.12%
202.40
+19.06%
170.00
+27.92%
132.90
Accounts Payable
178.20
+4.21%
171.00
+0.59%
170.00
+27.92%
132.90
Dividends Payable
54.80
+74.52%
31.40
Current Accrued Expenses
243.70
+6.93%
227.90
-8.88%
250.10
+18.47%
211.10
Current Debt And Capital Lease Obligation
70.10
-57.49%
164.90
+237.22%
48.90
-3.74%
50.80
Current Debt
43.60
-68.54%
138.60
+458.87%
24.80
-1.59%
25.20
Other Current Borrowings
43.60
-68.54%
138.60
+458.87%
24.80
-1.59%
25.20
Current Capital Lease Obligation
26.50
+0.76%
26.30
+9.13%
24.10
-5.86%
25.60
Other Current Liabilities
289.60
+17.82%
245.80
+31.16%
187.40
+3.48%
181.10
Total Non Current Liabilities Net Minority Interest
2,977.50
+4.68%
2,844.50
-9.66%
3,148.80
-1.56%
3,198.70
Liabilities Heldfor Sale Non Current
0.40
Long Term Debt And Capital Lease Obligation
2,643.80
+3.72%
2,548.90
-11.62%
2,883.90
-1.96%
2,941.50
Long Term Debt
2,447.20
+3.73%
2,359.20
-12.23%
2,687.80
-1.97%
2,741.80
Long Term Capital Lease Obligation
196.60
+3.64%
189.70
-3.26%
196.10
-1.80%
199.70
Non Current Deferred Liabilities
126.80
+20.53%
105.20
+20.92%
87.00
+4.82%
83.00
Non Current Deferred Taxes Liabilities
126.80
+20.53%
105.20
+20.92%
87.00
+4.82%
83.00
Other Non Current Liabilities
206.90
+8.67%
190.40
+7.03%
177.90
+2.12%
174.20
Preferred Securities Outside Stock Equity
Stockholders Equity
2,438.20
+17.96%
2,067.00
+25.46%
1,647.50
+25.73%
1,310.30
Common Stock Equity
2,438.20
+17.96%
2,067.00
+25.46%
1,647.50
+25.73%
1,310.30
Capital Stock
1.20
+0.00%
1.20
+0.00%
1.20
+9.09%
1.10
Common Stock
1.20
+0.00%
1.20
+0.00%
1.20
+9.09%
1.10
Share Issued
116.04
+0.00%
116.04
+0.54%
115.42
+0.56%
114.78
Ordinary Shares Number
100.00
-0.77%
100.78
+0.52%
100.25
+0.47%
99.78
Treasury Shares Number
16.04
+5.10%
15.26
+0.64%
15.16
+1.15%
14.99
Additional Paid In Capital
1,869.60
+1.22%
1,847.00
+3.36%
1,787.00
+3.28%
1,730.20
Retained Earnings
1,289.40
+61.84%
796.70
+95.99%
406.50
+251.34%
115.70
Gains Losses Not Affecting Retained Earnings
0.50
0.00
Treasury Stock
722.50
+25.02%
577.90
+5.61%
547.20
+1.96%
536.70
Minority Interest
837.60
+7.08%
782.20
+20.39%
649.70
+17.78%
551.60
Other Equity Adjustments
0.50
Total Equity Gross Minority Interest
3,275.80
+14.97%
2,849.20
+24.03%
2,297.20
+23.38%
1,861.90
Total Capitalization
4,885.40
+10.37%
4,426.20
+2.10%
4,335.30
+6.99%
4,052.10
Working Capital
69.50
+51.42%
45.90
-75.24%
185.40
+31.21%
141.30
Invested Capital
4,929.00
+7.98%
4,564.80
+4.69%
4,360.10
+6.94%
4,077.30
Total Debt
2,713.90
+0.00%
2,713.80
-7.47%
2,932.80
-1.99%
2,992.30
Net Debt
2,418.60
+0.26%
2,412.40
-8.74%
2,643.50
-3.70%
2,745.20
Capital Lease Obligations
223.10
+3.29%
216.00
-1.91%
220.20
-2.26%
225.30
Net Tangible Assets
812.30
+67.76%
484.20
+450.23%
88.00
+137.41%
-235.20
Tangible Book Value
812.30
+67.76%
484.20
+450.23%
88.00
+137.41%
-235.20
Interest Payable
38.60
-9.39%
42.60
-0.47%
42.80
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,175.60
+17.23%
1,002.80
+17.87%
850.80
+20.54%
705.80
Cash Flow From Continuing Operating Activities
1,177.00
+17.01%
1,005.90
+16.05%
866.80
+32.64%
653.50
Cash From Discontinued Operating Activities
-1.40
+54.84%
-3.10
+80.63%
-16.00
-130.59%
52.30
Net Income From Continuing Operations
760.10
+26.81%
599.40
+26.19%
475.00
+35.44%
350.70
Depreciation Amortization Depletion
327.90
+9.45%
299.60
+9.38%
273.90
+12.44%
243.60
Depreciation
299.60
+10.64%
270.80
+12.18%
241.40
+12.38%
214.80
Amortization Cash Flow
28.30
-1.74%
28.80
-11.38%
32.50
+12.85%
28.80
Depreciation And Amortization
327.90
+9.45%
299.60
+9.38%
273.90
+12.44%
243.60
Amortization Of Intangibles
28.30
-1.74%
28.80
-11.38%
32.50
+12.85%
28.80
Other Non Cash Items
6.10
-75.60%
25.00
+70.07%
14.70
-51.00%
30.00
Stock Based Compensation
56.50
+16.98%
48.30
-4.55%
50.60
+73.29%
29.20
Provisionand Write Offof Assets
0.00
Deferred Tax
22.30
+108.41%
10.70
+174.36%
3.90
-86.02%
27.90
Deferred Income Tax
22.30
+108.41%
10.70
+174.36%
3.90
-86.02%
27.90
Operating Gains Losses
-4.30
-43.33%
-3.00
+6.25%
-3.20
-113.33%
-1.50
Change In Working Capital
4.30
-80.37%
21.90
-56.46%
50.30
+265.46%
-30.40
Change In Receivables
-15.20
-606.67%
3.00
+113.39%
-22.40
-32.54%
-16.90
Changes In Account Receivables
-15.20
-606.67%
3.00
+113.39%
-22.40
-32.54%
-16.90
Change In Prepaid Assets
-31.20
+45.55%
-57.30
-1039.34%
6.10
-23.75%
8.00
Change In Payables And Accrued Expense
-6.70
-128.63%
23.40
-54.12%
51.00
+276.47%
-28.90
Change In Accrued Expense
15.90
-22.06%
20.40
-47.96%
39.20
+225.64%
-31.20
Change In Payable
-22.60
-853.33%
3.00
-74.58%
11.80
+413.04%
2.30
Change In Account Payable
-22.60
-853.33%
3.00
-74.58%
11.80
+413.04%
2.30
Change In Other Current Liabilities
57.40
+8.71%
52.80
+238.46%
15.60
+110.81%
7.40
Investing Cash Flow
-764.60
-17.04%
-653.30
-8.38%
-602.80
+3.86%
-627.00
Cash Flow From Continuing Investing Activities
-764.60
-17.04%
-653.30
-8.38%
-602.80
+3.32%
-623.50
Cash From Discontinued Investing Activities
0.00
0.00
+100.00%
-3.50
Net PPE Purchase And Sale
-736.40
-14.61%
-642.50
-10.19%
-583.10
+0.17%
-584.10
Purchase Of PPE
-736.40
-14.61%
-642.50
-10.19%
-583.10
+0.17%
-584.10
Capital Expenditure
-736.40
-14.61%
-642.50
-10.19%
-583.10
+0.17%
-584.10
Capital Expenditure Reported
-9.20
Net Business Purchase And Sale
0.00
Purchase Of Business
0.00
Net Intangibles Purchase And Sale
-10.10
Purchase Of Intangibles
-10.10
Net Other Investing Changes
-28.20
-161.11%
-10.80
+45.18%
-19.70
+50.00%
-39.40
Financing Cash Flow
-431.20
-30.43%
-330.60
-67.65%
-197.20
-35.35%
-145.70
Cash Flow From Continuing Financing Activities
-431.20
-30.43%
-330.60
-67.65%
-197.20
+70.16%
-660.80
Net Issuance Payments Of Debt
-29.00
+88.02%
-242.00
-190.52%
-83.30
+83.28%
-498.20
Issuance Of Debt
210.00
+121.05%
95.00
+18.75%
80.00
-68.23%
251.80
Repayment Of Debt
-239.00
+29.08%
-337.00
-106.37%
-163.30
+78.23%
-750.00
Long Term Debt Issuance
210.00
+121.05%
95.00
+18.75%
80.00
-68.23%
251.80
Long Term Debt Payments
-239.00
+29.08%
-337.00
-106.37%
-163.30
+78.23%
-750.00
Net Long Term Debt Issuance
-29.00
+88.02%
-242.00
-190.52%
-83.30
+83.28%
-498.20
Short Term Debt Issuance
Short Term Debt Payments
Net Short Term Debt Issuance
Net Common Stock Issuance
-158.00
-408.04%
-31.10
0.00
0.00
Common Stock Payments
-158.00
-408.04%
-31.10
0.00
0.00
Common Stock Dividend Paid
-71.10
-13.22%
-62.80
-3.97%
-60.40
+38.99%
-99.00
Cash Dividends Paid
-71.10
-13.22%
-62.80
-3.97%
-60.40
+38.99%
-99.00
Repurchase Of Capital Stock
-158.00
-408.04%
-31.10
0.00
0.00
Net Other Financing Charges
-173.10
-3366.04%
5.30
+109.91%
-53.50
+15.88%
-63.60
Changes In Cash
-20.20
-206.88%
18.90
-62.80%
50.80
+175.93%
-66.90
Beginning Cash Position
123.10
+18.14%
104.20
+95.13%
53.40
-55.61%
120.30
End Cash Position
102.90
-16.41%
123.10
+18.14%
104.20
+95.13%
53.40
Free Cash Flow
439.20
+21.90%
360.30
+34.59%
267.70
+119.97%
121.70
Interest Paid Supplemental Data
133.10
-9.33%
146.80
-0.61%
147.70
-17.21%
178.40
Income Tax Paid Supplemental Data
124.00
-24.62%
164.50
+50.50%
109.30
+113.48%
51.20
Change In Interest Payable
-1.70
Dividend Received CFO
4.10
+2.50%
4.00
+150.00%
1.60
-60.00%
4.00
Earnings Losses From Equity Investments
-4.30
-43.33%
-3.00
+6.25%
-3.20
-10.34%
-2.90
Cash From Discontinued Financing Activities
0.00
0.00
-100.00%
515.10
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category